Literature DB >> 7887242

Lessons from preclinical and clinical studies with 1,2-diethyl-3-hydroxypyridin-4-one, CP94 and related compounds.

J B Porter1, S Singh, K P Hoyes, O Epemolu, R D Abeysinghe, R C Hider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7887242     DOI： 10.1007/978-1-4615-2554-7_38

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

1.  Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.

Authors:  Yongmin Ma; Herbert de Groot; Zudong Liu; Robert C Hider; Frank Petrat
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 2.  The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.

Authors:  George J Kontoghiorghes; Marios Kleanthous; Christina N Kontoghiorghe
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-01-01       Impact factor: 2.576

3.  Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.

Authors:  Evangelia Vlachodimitropoulou; Yu-Lin Chen; Maciej Garbowski; Pimpisid Koonyosying; Bethan Psaila; Martha Sola-Visner; Nichola Cooper; Robert Hider; John Porter
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.